KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • Quest Diagnostics' Cash from Financing Activities fell 113.95% to -$247.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 191.84%. This contributed to the annual value of $1.1 billion for FY2024, which is 577.50% up from last year.
  • Per Quest Diagnostics' latest filing, its Cash from Financing Activities stood at $1.1 billion for FY2024, which was up 577.50% from $160.0 million recorded in FY2023.
  • Quest Diagnostics' 5-year Cash from Financing Activities high stood at $1.1 billion for FY2024, and its period low was -$2.5 billion during FY2021.
  • In the last 3 years, Quest Diagnostics' Cash from Financing Activities had a median value of $160.0 million in 2023 and averaged -$162.7 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 663.11% in 2020, then surged by 577.50% in 2024.
  • Quest Diagnostics' Cash from Financing Activities (Yearly) stood at -$1.3 billion in 2020, then tumbled by 100.47% to -$2.5 billion in 2021, then spiked by 31.81% to -$1.7 billion in 2022, then spiked by 109.24% to $160.0 million in 2023, then surged by 577.50% to $1.1 billion in 2024.